ConductScience.org, home

Paper4863911

The specific inhibition of the DNA-directed RNA synthesis by rifamycin.

Hartmann G and 3 others. Biochim Biophys Acta, 1967. Cited by 481 papers, by iCite.

Cite this record

ConductScience Library. The specific inhibition of the DNA-directed RNA synthesis by rifamycin. Papers, record 4863911. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4863911

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The specific inhibition of the DNA-directed RNA synthesis by rifamycin.
PubMed
Journal
Biochim Biophys Acta
PubMed
Year
1967
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
481
iCite
Revised in PubMed
2022-03-18
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hartmann GG
2Honikel KOK O
3Knüsel FF
4Nüesch JJ

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNAMajor topic
RNA, BacterialMajor topic
RifampinMajor topic
StaphylococcusMajor topic
Carbon Isotopes
DNA Nucleotidyltransferases
Depression, Chemical
Escherichia coli
Nucleotides
RNA Nucleotidyltransferases
Templates, Genetic
Thymus Gland
Uracil

Source PubMed

Download CSV of topics

Cited by189

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 481 citations.

PMIDTitleJournalYearIn PapersSource
42516079GapR stiffens AT-rich and overtwisted DNA leading to differential effects on transcription based on gene context.Nucleic Acids Res2026https://conductscience.org/library/papers/42516079PubMed
42427542Phosphoarginine modulates oligomerization and repressor activity of mycobacterial ClpC2.bioRxiv2026https://conductscience.org/library/papers/42427542PubMed
41729463Rifaximin's therapeutic spectrum: approved indications and experimental insights into emerging uses.Pharmacol Rep2026https://conductscience.org/library/papers/41729463PubMed
41104949Principles of bacteriostatic and bactericidal antibiotics at subinhibitory concentrations.mBio2025https://conductscience.org/library/papers/41104949PubMed
40757508Low-complexity automated nucleic acid amplification tests for extrapulmonary tuberculosis and rifampicin resistance in adults and adolescents.Cochrane Database Syst Rev2025https://conductscience.org/library/papers/40757508PubMed
40728034Xpert MTB/RIF Ultra assay for pulmonary tuberculosis and rifampicin resistance in adults and adolescents.Cochrane Database Syst Rev2025https://conductscience.org/library/papers/40728034PubMed
40552714Nonequilibrium polysome dynamics promote chromosome segregation and its coupling to cell growth in Escherichia coli.Elife2025https://conductscience.org/library/papers/40552714PubMed
40430474Development of Rifampicin Eye Drops for the Treatment of Exudative Age-Related Macular Degeneration.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40430474PubMed
37403359Environmental conditions define the energetics of bacterial dormancy and its antibiotic susceptibility.Biophys J2023https://conductscience.org/library/papers/37403359PubMed
37397488Bifunctional antibiotic hybrids: A review of clinical candidates.Front Pharmacol2023https://conductscience.org/library/papers/37397488PubMed
37289062Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis.Microbiol Spectr2023https://conductscience.org/library/papers/37289062PubMed
37237771Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy.Antibiotics (Basel)2023https://conductscience.org/library/papers/37237771PubMed
36881456A novel proteinaceous molecule produced by Lysinibacillus sp. OF-1 depends on the Ami oligopeptide transporter to kill Streptococcus pneumoniae.Microbiology (Reading)2023https://conductscience.org/library/papers/36881456PubMed
36841858An Overview of Mycoviral Curing Strategies Used in Evaluating Fungal Host Fitness.Mol Biotechnol2023https://conductscience.org/library/papers/36841858PubMed
36761902Past, current, and potential treatments for cryptosporidiosis in humans and farm animals: A comprehensive review.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/36761902PubMed
36714853C25-modified rifamycin derivatives with improved activity against Mycobacterium abscessus.PNAS Nexus2022https://conductscience.org/library/papers/36714853PubMed
36584037High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia.PLoS One2022https://conductscience.org/library/papers/36584037PubMed
36339603Involvement of endoplasmic reticulum stress in rifampicin-induced liver injury.Front Pharmacol2022https://conductscience.org/library/papers/36339603PubMed
36290036Molecular Basis of Non-β-Lactam Antibiotics Resistance in Staphylococcus aureus.Antibiotics (Basel)2022https://conductscience.org/library/papers/36290036PubMed
36228001A machine learning model trained on a high-throughput antibacterial screen increases the hit rate of drug discovery.PLoS Comput Biol2022https://conductscience.org/library/papers/36228001PubMed

See all 189 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4863911

GET https://conductscience.org/api/papers/v1/4863911/cited_by?page=2